| Stay updated on the top DIGITAL HEALTH NEWS |
|---|
|
|
The U.S. Food and Drug Administration released final guidance establishing a clear framework for how drug companies can develop, distribute, and label apps used alongside their prescription medicines. The guidance ends longstanding uncertainty by providing recommendations about when app content is subject to FDA submission requirements, when an app should be mentioned on a drug’s official label, and what companies should submit to the agency.
The paper, written by researchers at Binghamton University, Stanford University, Texas A&M University, and Indiana University, and published in Nature Health, examines what happens when a chatbot gives someone bad health advice.
The European Commission welcomes the positive opinion given by the Member States on the EU4Health Work Programme for 2026, which will support the implementation of EU priorities in the area of public health such as the Safe Hearts Plan, Critical Medicines Act and the European Health Data Space.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the five-year EXIT-CVD research project, co-funded by the European Union Innovative Health Initiative (IHI) and the industry partners. The research consortium is led by University Medical Center Groningen (UMCG) and Philips, and aims to transform how cardiovascular disease is detected, monitored and treated.
The rationale always tracks back to efficiency: AI-technology will achieve more with less. In theory, greater efficiency contributes to sustainability.
The studies included in a new George Mason review capture some of these newer approaches.